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Abstract
WD-repeat proteins are very diverse, yet these are structurally related proteins that participate in a wide range of cellular
functions. WDR13, a member of this family, is conserved from fishes to humans and localizes into the nucleus. To
understand the in vivo function(s) of Wdr13 gene, we have created and characterized a mutant mouse strain lacking this
gene. The mutant mice had higher serum insulin levels and increased pancreatic islet mass as a result of enhanced beta cell
proliferation. While a known cell cycle inhibitor, p21, was downregulated in the mutant islets, over expression of WDR13 in
the pancreatic beta cell line (MIN6) resulted in upregulation of p21, accompanied by retardation of cell proliferation. We
suggest that WDR13 is a novel negative regulator of the pancreatic beta cell proliferation. Given the higher insulin levels
and better glucose clearance in Wdr13 gene deficient mice, we propose that this protein may be a potential candidate drug
target for ameliorating impaired glucose metabolism in diabetes.
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Introduction
WD (tryptophan and aspartate)-repeat proteins belong to a large
family of structurally related proteins, members of which have
diverse functions such as cell cycle regulation, transcription,
chromatin organization and protein trafficking [1,2]. These
proteins provide a platform for protein-protein interactions.
WDR13 protein is a member of this family and localizes to the
nucleus [3]. Wdr13 gene is highly conserved in vertebrates. This
gene is located on the X-chromosome at locus Xp11.23 and
XA1.1 in human and mouse, respectively. In human, X
chromosomal deletions including this gene have been associated
with mental retardation, obesity and xeroderma [4,5,6,7]. Wdr13
gene expresses in most of the tissues [8], the highest level of
expression being in pancreas, brain, testis and ovaries. Several
WD-repeat proteins have been identified that are expressed in
pancreatic beta cells and have roles in beta cell proliferation
[9,10].
The beta cell mass is regulated by the balance between
neogenesis/proliferation and apoptosis/necrosis. In mice, differ-
entiation of islet precursor and expansion are responsible for beta
cell neogenesis until the first week of life [11,12]. Thereafter,
expansion of existing beta cells is the main source of newly formed
beta cells [13,14]. In pathological conditions there can be alpha to
beta cell trans-differentiation [15]. Various cell cycle regulators
have been identified that have role in pancreatic beta cell
proliferation [16]. Cell cycle progression in pancreatic islet is
controlled by cyclins, cyclin dependent kinases (CDKs), cyclin
dependent kinase inhibitors and hormones [16,17].
Pancreatic islet mass, insulin production and body weight are
inter-related [12,18]. Insulin levels have been positively correlated
with obesity in humans [19] and rodents [20]. Generally, obesity
leads to higher demand for insulin production and the same is met
by increase in beta cell mass. Obesity is also a major risk factor for
the onset of peripheral insulin resistance [21]. Insulin resistance
leads to further higher demand for insulin from beta cells, and
eventually triggering beta cell failure. This results in beta cell
survival defects, insufficient beta cell mass and deterioration of the
key beta cell function i.e. glucose stimulated insulin secretion, and
ultimately type 2 diabetes. Thus, the mass of insulin producing
beta cells changes dynamically according to the metabolic
conditions [22,23]. Alternatively, obesity may be a consequence
of higher insulin levels [24,25,26] as insulin has stimulatory effect
on adipogenesis by increasing the lipid accumulation in adipocytes
[27,28,29]. Insulin is also involved in adipocyte survival [30].
Adipose tissue-specific insulin receptor gene knockout protects
against obesity, emphasizing that insulin signaling to adipocytes is
important for development of obesity [28]. Hyper insulin secretion
in MOR-1 opioid receptor knockout mice results in higher body
weight [26] whereas CHOP knockout mice become obese with
increasing insulin secretion although glucose tolerance remains
unchanged in these mice [31].
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e38685To understand the in vivo role of Wdr13 gene, we have created
a mouse strain lacking this gene and show that these mice have
higher pancreatic islet mass as a result of higher beta cell
proliferation, develop hyperinsulinemia and mild obesity.
Results
Generation of Wdr13 knockout mice
Wdr13 is a single copy gene located on the X-chromosome [8].
The targeting strategy was designed to substitute exon 2, intron 2
and exon 3 (partial) of the endogenous gene with neomycin gene
cassette containing polyA (Figure 1A). Targeted ES cell clones
were identified by southern blot (Figure 1B). Chimaeras were
generated from one of the targeted ES cell clones after injecting
these cells into C57BL/6 blastocysts. Male chimaeras were bred
with CD-1 females and germ line transmission from the ES cell
component was identified by the presence of agouti progeny. The
mutant allele in these progeny was further confirmed by southern
blot. Northern blot analysis using Wdr13 cDNA probe revealed the
lack of 4 kb and 2 kb transcripts from brain and testis of the
knockout mice, respectively as compared to that from the wild type
mice (Figure 1C). Further, western blot using anti WDR13
antibody showed the absence of WDR13 protein in various tissues
of the knockout mice (Figure 1D, E). These results confirmed that
targeting of Wdr13 gene had led to the generation of a null allele.
Wdr13 knockout mice were viable and fertile
Wdr132/0 male and Wdr132/2 female knockout mice were
viable and fertile. Given the comparatively high level of expression
of Wdr13 gene in spermatogonia and spermatocytes, and the
presence of a different size transcript in testis [8], we analysed the
litter size from various matings involving the mutant and wild type
mice. The genotypes of the parents had no effects on the litter size
(Table S1). The sperm number from Wdr132/0 males (40.665.49
million/ml) was similar to that of Wdr13+/0 (37.963.05 million/
ml).
Increased body weight of Wdr13 knockout mice
Wdr13 deficient mice differentiated in body weight from their
wild type littermates around nine months of age when fed normal
chow. At 11 months the mutant male and female mice had 13%
and 11% higher body weights (P#0.05), respectively than their
littermates (Figure 2A, B). The weight of epididymal fat pad was
2.5-fold more in Wdr132/0 mice in comparison to that of wild
type, whereas the weight of ovarian fat pad was 2- fold more in
Wdr132/2 in comparison to that of the wild type (Figure 2D).
Histological examination of epididymal fat pad revealed adipocyte
hypertrophy in Wdr13 knockout mice (Figure 2C). Adipocyte
hypertrophy was also noticed in skin sections of the mutant mice.
Various organs including, brain, lung, heart, liver, pancreas,
spleen and testis of the mutant and wild type mice were weighed at
12 months. The mutant mice had significantly higher pancreatic
weight. There was no difference in the weights of other organs
(Table S2). To understand the effect of diet on the higher body
weight of the mutant mice, one month old mice were kept on
a high fat (60%) diet and their body weights were followed.
Interestingly, Wdr132/0 weighed significantly more at five
months (Figure 2I) indicating the advancement of the obesity
phenotype of the mutant mice.
Glucose and insulin levels in Wdr13 knockout mice
Given the age-dependent obesity phenotype, we measured
fasting and random blood glucose levels at different age points in
mice fed with normal chow (Figure 2E, F). There was no effect of
Wdr13 genotype on fasting glucose levels. Similarly, the random
glucose levels at 2 months did not differ between the mutant and
wild type mice. However, the mutant mice showed lower random
glucose at 12 months on normal chow. In the light of lower
random glucose at 12 months, we estimated the serum insulin
levels. The fasting insulin levels were similar in the wild type and
mutant mice at both age points (Figure 2G). While random insulin
levels in Wdr13 deficient and wild type mice at 2 months were
similar, interestingly, at 12 months the mutant mice had 2.13 fold
more random insulin level on normal chow (Figure 2H). Similarly,
the mutant mice had 1.6-fold more random insulin levels at six
months when fed on a high fat diet (Figure 2J).
Increased glucose clearance but unaltered insulin
sensitivity in Wdr13 knockout mice
Given the high level of random insulin in Wdr13 deficient mice,
we challenged these mice with glucose to determine their glucose
clearance at 2 months and 12 months on normal chow, and at 6
months on a high fat diet. The mutant and wild type mice showed
similar glucose clearance (Figure 3A) at 2 months. At 12 months
the mutant mice appeared to have marginally better glucose
clearance; however, the difference was statistically non-significant
(Figure 3B). However, the mutant mice showed consistently better
glucose clearance at 6 months on a high fat diet (Figure 3C).
Insulin tolerance test (ITT) at 2 months (Figure 3D) and 12
months (Figure 3E) did not reveal any difference between the
mutant and wild type mice fed on normal chow, indicating that
insulin sensitivity was similar in these two groups. Consistent with
this, insulin sensitivity in the mutant mice at 6 months (Figure 3F)
and 9 months (Figure 3G) was similar to that of wild type mice
when fed on a high fat diet.
Increased islet mass and beta cell proliferation in Wdr13
knockout mice
Since Wdr13 deficient mice were hyperinsulinemic and mildly
obese, we analyzed the pancreatic histology at 6 months in these
mice when fed on a high fat diet. Interestingly, total islet mass was
significantly more in Wdr13 knockout mice at 6 months (Figure 4A,
B). To understand the increased islet mass, we measured beta cell
proliferation by in-situ BrdU labeling. Briefly, one month old mice
were kept on a high fat diet for three weeks before infusion of
BrdU and we observed a 2-fold more proliferation of beta cells in
Wdr13 mutant mice as compared to their wild type littermates
(Figure 4C, D).
Higher insulin level in knockout mice is due to the
increased islet mass rather than insulin secretion per unit
islet
Given the better glucose clearance in Wdr132/0 mice, glucose
was injected into 6 month old (on high fat diet) fasting mice and
the insulin secretion was monitored at different time points
(Figure 4E). Insulin secretion after 30 minutes of glucose injection
was 1.8 fold more in Wdr132/0 mice. The higher insulin levels in
the mutant mice might result from the increased islet mass
observed by us in these mice (Figure 4A, B) or might from higher
insulin secretion per unit beta cell in response to glucose
stimulation. To rule out the latter possibility, we isolated islets
from 3 month old Wdr132/0 mice and their wild type littermates
(n=3). Twenty-five equal sized islets from each mouse were
induced with 16 mM glucose and insulin secretion was measured
after 60 minutes. There was no difference in the in vitro insulin
secretion between the mutant and wild type islets (Figure 4F).
Role of Wdr13 Gene in Beta Cell Proliferation
PLoS ONE | www.plosone.org 2 June 2012 | Volume 7 | Issue 6 | e38685Overexpression of Wdr13 gene results in cell growth
retardation
To further understand the role of Wdr13 gene in beta cell
proliferation, WDR13 protein was overexpressed in MIN6 cell line
using pAd Easy system. MIN6 cells were transfected with AdGFP
and AdWdr13 with 100 MOI each in 24 well plates. After
48 hours of transfection, overexpression of Wdr13 gene was
confirmed by western blot (Figure 5A) using anti WDR13
antibody. Further, we studied the growth curve of MIN6 cells
by counting cells after overexpression of Wdr13 gene. A significant
reduction in cell growth was observed 48 h post transfection
(Figure 5A).
Effect of WDR13 on cell cycle regulators
To understand the growth retardation after overexpression of
WDR13, various cell cycle regulators were analyzed by western
blotting. The protein levels of cyclin D1, cyclin D2, cyclin E and
p27 were unaltered, whereas p21 was highly upregulated
(Figure 5B). Conversely, siRNA knockdown of Wdr13 gene
showed downregulation of p21 protein levels (Figure 5C). Further,
consistent with these results western blot analysis revealed
reduction in p21 levels in the islets from Wdr13 knockout mice,
(Figure 5D). To understand the nature of p21 regulation by
WDR13, promoter occupancy of WDR13 protein was analyzed at
p21 promoter. Chromatin immunoprecipitation experiment
showed interaction of WDR13 with p21 promoter sequences
indicating a role of WDR13 in p21 regulation (Figure 5E).
Discussion
In the present study, we have examined the in vivo role of one of
the WD repeat proteins, namely, WDR13 by knocking out this
gene in mouse. The mutant mice were viable and fertile without
any overt phenotype except that the mice were significantly
heavier than their wild type littermates at around nine months and
continued to weigh more till the termination of the growth
experiment at 12 months when fed on normal chow. This age-
Figure 1. Generation of Wdr13 knockout mice. A) Exon2 and exon3 (partial) of Wdr13 gene were replaced by neomycin resistance marker gene.
B) Southern blot analysis showing 9.3 kb EcoRI fragment from the wild type allele and 3.8 kb fragment from the mutant allele using a 700 bp probe
from 59 end of the locus. C) Northern blot analysis by Wdr13 cDNA probe showing the absence of Wdr13 transcript in Wdr132/0 mice (upper panel)
and ethidium bromide staining as loading control (lower panel). D) Western blot analysis from testis, pancreas and purified islets using anti-WDR13
rabbit polyclonal antibody (upper panel) showing the absence of WDR13 protein in Wdr132/0 mice, and anti-beta actin as loading control (lower
panel). The expression of WDR13 is extremely high in islets in comparison to acinar cells. E) Expression of WDR13 protein in insulin sensitive tissues
such as liver, pancreas, muscle and adipose tissues using anti WDR13 antibody (upper panel) and posceau stained blot as loading control (lower
panel). (+/0 wild type male; 2/0 knockout male).
doi:10.1371/journal.pone.0038685.g001
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five months when these mice were fed on a high fat diet (Figure 2I).
Anatomical and histological examination revealed that the in-
creased body weights of the mutant mice were mainly due to the
increase in the adipose tissue volume/weight resulting from
hypertrophy of adipocytes without any indication of change in
adipocyte numbers (Figure 2C).
Wdr13 knockout mice were mildly obese, and random insulin
levels in these mice were ,2 fold higher as compared to their wild
type littermates at 12 months on normal chow and at 6 months on
a high fat diet. However, there was no difference in fasting insulin
levels. Dynamic changes in the insulin-producing pancreatic beta
cell mass are dependent on metabolic conditions, and positive
correlations between body weight, insulin production and islet
mass are well documented [12,32]. Various studies have shown
that the increase in insulin levels may be a compensatory
mechanism to the decreased peripheral insulin sensitivity in
response to obesity, ultimately leading to islet failure and to type 2
diabetes [33]. On the other hand, it is also known that higher
insulin levels result in higher glucose uptake by adipose tissues,
Figure 2. Body weight, body composition, and glucose and insulin levels of Wdr13 knockout mice fed on normal chow and high fat
diet. A) Growth curve of Wdr13+/0 male, Wdr132/0 male, Wdr13+/+ female, Wdr13+/2 female and Wdr132/2 female (n=12) on normal chow. B)
Increased adipose tissue mass in Wdr132/0 mice. C) H&E staining of a section of epididymal fat pad of Wdr132/0 mouse showing hypertrophy of
adipose tissues D) Weight of epididymal fat pad in male and ovarian fat pad in female at 12 months (n=6) of the mutant and wild type mice. E)
Sixteen hours fasting glucose level in Wdr13 knockout mice at 2 months and 12 months. F) Random fed glucose level in Wdr13 knockout mice at 2
months and 12 months G) Fasting insulin level in Wdr13 knockout mice at 2 months and 12 months H) Random fed insulin level in Wdr13 knockout
mice at 2 months and 12 months. I) Growth curve of Wdr13+/0 male and Wdr132/0 male on high fat diet (n=10 to12). J) Fasting and fed insulin level
in Wdr132/0 mice and in their wild type littermates at 6 months. (+/0 wild type male; 2/0 knockout male; +/+ wild type female; +/2 heterozygous
female; 2/2 knockout female).
doi:10.1371/journal.pone.0038685.g002
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[34]. Consistent with the latter findings, insulin receptor knockout
mice exhibited decreased adipose tissue [35]. Insulin stimulates
hepatic lipogenesis as well as fatty acid uptake in adipocytes
leading to increased adipose tissue formation [27]. Moreover,
insulin receptor glucose transporter-4 pathway helps to convert
glucose to lipid in adipose tissues [34]. In addition to the role of
insulin in adipogenesis, insulin secretion has been positively
correlated with obesity in humans [19], rodents [20] and non
mammalian avian models [36]. In Wdr13 knockout mice, islet
mass, insulin levels and glucose-stimulated insulin secretion were
more at 6 months on a high fat diet. Notwithstanding higher body
weights at 6 month and onwards, the mutant mice had better
glucose clearance, without any indication of diabetes till the
termination of experiments at 9 months of age in the case of a high
fat diet and 12 months on normal chow (Figure 3). Further, ITT
experiments showed similar insulin sensitivity in Wdr13 knockout
mice as their wild type littermates. However, the lack of insulin
resistance as revealed by ITT data would require confirmation
using hyperinsulinemic clamp studies. Nevertheless, it appears that
the body weight gain in Wdr13 knockout mice may be
a consequence of insulin hypersecretion, which in turn may alter
adipogenesis in fat cells. Hyperinsulinemia, accompanied by mild
obesity in Wdr13 knockout mice appears to be reminiscent of
MOR1 [26] and chop [25,31] knockout mice, where adiposity is
enhanced by higher insulin secretion. It may be recalled that
Wdr13 gene is expressed at high levels in brain and at moderate
levels in liver and adipose tissues (Figure 1). Therefore, we cannot
Figure 3. Glucose tolerance test (GTT) and Insulin tolerance test (ITT) of Wdr13 knockout mice. A) GTT at 2 months on normal chow
(n=8–12). B) GTT at 12 months on normal chow (n=8–10). C) Glucose tolerance test at 6 months on high fat diet (n=8). D) ITT at 2 months on
normal chow (n=8–12). E) ITT at 12 months on normal chow (n=8–10). F) Insulin tolerance test at 6 months on high fat diet (n=8) G) ITT at 9 months
on high fat diet (n=6–8). (+/0 wild type male; 2/0 knockout male).
doi:10.1371/journal.pone.0038685.g003
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reflected the deficiency of this protein in any one or all of these
tissues. In this context, it may be noted that the food intake in
Wdr13 knockout mice was marginally higher than that in wild type
littermates (Figure S1); the difference was statistically non-
significant. Although our in-vitro data in MIN6 cells as well as
hyperinsulinemia and better glucose clearance in Wdr13 knockout
mice show functional significance of WDR13 protein in pancreatic
beta cells, a tissue-specific knockout of Wdr13 gene will be
necessary to confirm that the gross changes observed by us in the
mutant mice are direct consequences of alterations in beta cell
function in these mice.
We have earlier reported relatively higher level of expression of
Wdr13 in pancreas [3], and the expression of this gene in the
pancreatic islets is much more as compared to extremely low levels
seen in the acinar cells (Figure 1D). Wdr13 knockout mice had
more pancreatic islet mass than their littermates when fed on
a high fat diet for five months after weaning at one month. To
understand the phenomenon of the increased islet mass, we
assayed in vivo beta cell proliferation after one-month old mice
were fed on a high fat diet for three weeks. Wdr13 knockout mice
had enhanced beta cell proliferation as compared to that in their
wild type littermates (Figure 4C, D). We have not analyzed the
proliferation rates of other cell types in the pancreatic islets. Given
the fact that beta cells contribute to 80–85% mass of pancreatic
islets, it would appear that the increase in islet mass in Wdr13
knockout mice might be primarily due to the enhanced beta cell
proliferation. This conclusion is further strengthened by reversal of
the cell proliferation phenotype i.e. the growth retardation
observed by us in the pancreatic MIN6 cells upon overexpression
of Wdr13 gene (Figure 5A). The lack of difference between in vitro
insulin secretion capacities of the wild type and knockout
pancreatic islets (Figure 4F) provides further indirect support to
the above conclusion. Various extrinsic and intrinsic factors
Figure 4. Histology of pancreatic islet, pancreatic beta cell proliferation, in-vivo and in-vitro insulin secretion in Wdr13 knockout
mice. A) Islet morphology showing increased islet mass by H&E staining. B) Islet mass in mg at 6 months on high fat diet showing increased total islet
mass in Wdr13 knockout mice (n=4). C) Percent of dividing cells in islets by BrdU labeling (n=309–517). D) Analysis of pancreatic beta cells
proliferation analysis by BrdU labeling showing more proliferating beta cells in Wdr13 knockout islets. E) In-vivo insulin secretion in response to
glucose at 6 months (n=4 to 6). F) In-vitro insulin secretion from isolated pancreatic islet of the wild type and Wdr13 knockout mice at 2.8 mM or
16 mM glucose concentration (+/0 wild type male; 2/0 knockout male).
doi:10.1371/journal.pone.0038685.g004
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Many positive regulators of beta cells exist which include incretins
[37], EGF [38], lactogens and growth hormones [39], HNF-4a
[40], calcineurin/NFAT [41], Wnt3a [42] and integrins [43].
Various cell cycle inhibitors (p15, p16, p18, p19, p21, p27 and
p57) have been identified, which target either various cyclins or
cyclin dependent kinases to inhibit progression at various stages of
the cell cycle [16]. In the present study, overexpression of WDR13
in pancreatic MIN6 cell line resulted in significantly higher p21
protein level, while cyclin D1, cyclin D2, cyclin E and p27 levels
remained unaltered (Figure 5B). Further, through ChIP assay, we
have identified occupancy of p21 promoter by WDR13 in
pancreatic MIN6 cells. Consistent with these results, knockdown
of WDR13 using siRNA in MIN6 cells and Wdr13 knockout
pancreatic islets showed downregulation of p21 protein (Figure 5C,
D). Cozar-Castellano et al., [44] observed an inhibitory role of p21
on beta cell proliferation in mice transgenic for hepatocyte growth
factor and placental lactogen. However, in another study this
group showed that knockout of p21 did not affect beta cell
proliferation [45]. It might be possible that other protein(s)
compensated the complete loss of p21 in beta cells in the latter
study.
WD-repeat proteins provide a platform for protein-protein
interactions [1]. WDR13 protein contains five putative WD
repeats and a LxxLL motif at c-terminal. It is possible that
WDR13 mediates its effect (s) by interacting with other proteins.
The effect of WDR13 on p21 levels observed by us in the present
study may be the result of either direct or indirect interactions of
this protein with p21 promoter. However, no DNA binding
domain has been predicted in WDR13 [8]. Therefore, it is
probable that WDR13 may either be activating p21 promoter by
interacting with other proteins or repressing a repressor of p21.
Our results will be useful in further unraveling the mechanisms of
beta cell cycle regulation. It may be recalled that Wdr13 gene is
expressed in most of the tissues and some of the interactions of this
protein with its partners may even turn out to be tissue-specific;
consequently, the precise mechanism(s) of action may differ in
different tissues and/or at different target genes. Extensive CHIP
experiments will be necessary to unravel different target genes of
WDR13 and to understand the mode of action of this protein at
these loci in various cell types.
In conclusion, we provide evidence that WDR13 deficiency in
mice leads to increased pancreatic islet mass, hyperinsulinemia,
better glucose clearance and mild obesity. Our present study
reveals a role of WDR13 in regulation of beta cell proliferation
and these results provide a basis for further investigations aimed at
delineating the mechanisms of action of WDR13 in cell cycle
regulation through p21 and other as yet unidentified targets of this
protein. We propose that given the higher random insulin levels
and better glucose clearance in Wdr13 knockout mice, this protein
may be explored as a potential candidate drug target for
ameliorating impaired glucose metabolism in diabetes.
Figure 5. Effect of WRD13 levels on pancreatic beta cell proliferation and cell cycle regulators. A) Transfection with AdWdr13 and AdGFP
viruses shows overexpression of WDR13 protein in MIN6 cells as visualized by immunoblotting using anti WDR13 antibody. Lower panel shows beta
actin as loading control. Overexpression of WDR13 protein results in retardation in cell proliferation after 48 h of transfection with 100 MOI. B)
Overexpression of WDR13 protein results in accumulation of p21, whereas Cyclin D1, Cyclin D2, Cyclin E1 and p27 levels remain unaffected. C) siRNA
knockdown of WDR13 in MIN6 cells. MIN6 cells were transfected with nonspecific scrambled (Scr) siRNAs and WDR13 specific siRNA. Immunoblot
analysis shows Knockdown of WDR13 protein. Actin was used as loading control. Immunoblot, using p21 antibody shows reduction of p21 levels in
WDR13 knockdown MIN6 cell. D) Cell cycle inhibitor p21 expression in purified pancreatic islets of Wdr13 knockout mice and that of wild type
littermates by western blot analysis. Beta actin was used as loading control. p21 expression is less in the islets of knockout mice. E) Occupancy by
WDR13 at p21 promoter revealed by chromatin immunoprecipitation using primers specific for p21 and GAPDH.
doi:10.1371/journal.pone.0038685.g005
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Ethics statement
The institutional Animal Ethics Committee of the Centre for
Cellular and Molecular Biology, Hyderabad, India approved all
the mice experiments.
Generation of Wdr13 null mice
To construct the Wdr13 gene targeting vector, a 7.1 kb HindIII
fragment from this gene including exon1 to exon7 was sub-cloned
in pBluescript II KS vector (Stratagene). A 1.35 kb region from
this fragment spanning exon 2 and exon 3 (partial) was replaced by
XhoI-SalI fragment of pMC1neo Poly A (Stratagene). To further
enrich for the targeting events, a negatively selectable HSV-tk
gene was placed before the 59 end of the homologous sequences
from Wdr13 gene. The resulting vector had homologies of 1.6 kb
and 4.1 kb at the 59 and 39ends, respectively. Forty micrograms of
linearized targeting vector DNA was electroporated into R1 ES
cells [46]. The ES cells were selected with G418 (0.25 mg/ml) and
ganciclovir (2 mM). To identify the targeted clones, genomic DNA
was isolated from ES cells and southern hybridization was
performed using a 700 bp EcoRV-BamHI fragment as a probe
from the 59 end of this locus. One of the targeted clones was
injected into 3.5-dpc C57BL/6 blastocysts and the latter were
transferred into the uteri of CD1 pseudopregnant females. To
obtain germline transmission of the mutant allele, chimaeric male
mice were mated with CD1 females. Germ line transmission was
confirmed by southern analysis. PCR was used for regular
screening of mutant mice using a primer pair (Table S3) from
the Wdr13 locus and another primer pair from neomycin gene.
Northern blot and western blot analysis
Various tissues were snap frozen in liquid nitrogen and stored at
280uC till further use. Total RNA was isolated using RNeasy
Mini Kit (Qiagen). For Northern analysis, RNA was electrophor-
esed on 1% agarose gel containing 2.2 M formaldehyde and
blotted on hybond N+ membrane with 50 mM NaOH. Wdr13
cDNA was radio labeled with adATP using random priming kit.
Hybridization was performed overnight at 65uC in 0.5 M
phosphate buffer/7% SDS/1 mM EDTA and the membranes
were then washed 36 at 65uC in 40 mM phosphate buffer/1%
SDS/1 mM EDTA. The membranes were exposed to X-ray
sheets (Fuji films) and developed. Proteins were extracted from
various tissues, separated on 10% SDS-PAGE, blotted on PVDF
membranes and western blots were performed. Anti-WDR13
antibody (HPA000913) from Sigma and p21 (sc-397), p27 (sc-528),
cyclinD1 (sc-246), cyclinD2 (sc-593) and cyclinE (sc-481) from
Santacruz were used for visualization of the respective protein.
Animal weight measurement, feed consumption and
body composition
Mice were housed in temperature, humidity and light/dark
cycle (12 hrs 6am- 6pm) controlled animal rooms. Autoclaved
normal diet or high fat diet was fed ad libitum, and the feed intake
was measured weekly. Mice were weighed fortnightly. To
determine the body composition, mice were dissected and the
weights of various organs were measured.
GTT, ITT, and insulin measurements
Blood glucose was measured with a glucometer using Sensor
Comfort strips (Accu-Check) and insulin was measured by ELISA
kits (Linco Research). To compare glucose clearance and insulin
secretion, the mice were kept off-feed for 16 hours, glucose was
injected intraperitoneally (2.0 grams glucose/Kg body weight) and
blood was collected at 0, 30, 60 and 120 minutes intervals. Insulin
tolerance was estimated by measuring glucose levels at 0, 30, 60
and 120 minutes intervals after injecting human insulin intraper-
itoneally (1 U/kg).
Islet isolation and in-vitro insulin secretion
Pancreatic islets were isolated from the wild type and knockout
mice as described by Wen et al. [26]. Briefly, 2 mg/ml collagenase
type IV (Invitrogen) dissolved in Hanks’ balanced salt solution
(HBSS) was injected into common bile duct and pancreas were
incubated at 37uC for 30 minutes. After collagenase digestion,
pancreatic tissue was washed twice with cold HBSS and islets were
purified by Ficoll gradient. The purified islets were washed two
times with HBSS and transferred to RPMI1640 medium
supplemented with 10% fetal bovine serum 100 U/ml penicillin,
and 50 mg/ml streptomycin for overnight recovery. The islets were
transferred next morning to Krebs–Ringer bicarbonate buffer
(111 mM NaCl, 4.8 mM KCl, 2.3 mM CaCl2, 1.2 mM MgSO4,
25 mM NaHCO3) supplemented with 10 mM HEES, 2.8 mM
glucose, 0.2% BSA and incubated for 90 minutes at 37uC with 5%
CO2. To measure the insulin secretion in vitro, five equal size islets
were plated (in triplicate) in a single well of 96-well plate
containing either 250 ml Krebs–Ringer bicarbonate buffer/
2.8 mM glucose or 250 ml Krebs–Ringer bicarbonate buffer/
16.0 mM glucose and were incubated for 1 h at 37uC with 5%
CO2. The supernatant was collected and stored at 280uC for
insulin measurement.
Cell proliferation assay, histology and immunostaining
To assay beta cell proliferation, BrdU was given to mice in
drinking water (1 mg/ml) for 7 days. For histological examination,
tissues were fixed overnight in buffered 4% para formaldehyde,
embedded in paraffin and sectioned (4 mm thickness). Sections
were mounted on positively charged slides (Fisher Scientific) and
were stained with either hematoxylin-eosin or subjected to
immunostaining with anti-insulin (R&D System) and anti-BrdU
(BD Biosciences) antibodies. Primary antibody was detected by cy3
or FITC-conjugated antibodies.
Pancreatic and islet areas were measured from pancreatic
sections from four mice each of the wild type and mutant
genotypes using Axioskop (Axivision software). Islet mass per
pancreas was calculated by multiplying relative islet area with wet
mass of pancreas.
Adenovirus generation and cell proliferation assay
To overexpress WDR13 protein in various cell lines, Wdr13
adenovirus constructs were generated. In brief, Wdr13 cDNA was
amplified from pCMV-FLAG-Wdr13 vector using T7 forward
primer and reverse primer 59GCTCTAGAGCAGCACAGGGT-
GACAGAACC39, digested with PmeI and cloned at EcoRV of
pAdTrack-CMV vector. AdGFP or AdWdr13 were generated in
HEK293T packaging cell line according to He et al., [47]. 10,000
MIN6 cells (obtained from National Centre for Cell Science, Pune,
India) were seeded per well of 24 well plates [48] in DMEM media
containing 10% FBS and were transfected either with AdGFP or
AdWdr13 using a titer of 100 MOI. Cell number was monitored
by MTT assay at 24 h interval. For western blot analysis, MIN6
cells were transfected with AdGFP or AdWdr13 virus (100 MOI)
and the cells were lysed 48 hour post transfection.
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MIN6 cells were transfected with non-specific scrambled (Scr)
siRNA (Sc-37007) and Wdr13-specific siRNA (Sc-155258-Santa-
cruz) using lipofectamin TM2000 (Invitrogen) in 30 mm dish
(100 pmole each). The cells were lysed after 72 h post transfection
and analyzed by immunoblotting.
Chromatin immunoprecipitation
MIN6 cells were transfected with AdGFP and AdWdr13 using
20 MOI and allowed to grow for 48 hours. The cells were
crosslinked in 1% formaldehyde for 10 minutes at room temper-
ature and scraped in PBS containing protease inhibitors.
Chromatin immunoprecipitation was performed using the chro-
matin immunoprecipitation (ChIP) Assay Kit, Millipore (Cata-
logue Number: 17–295) as per the manufacturer’s instructions.
Briefly, cell lysate was precleaned by incubating in agarose beads
for 1 h at room temperature followed by immunoprecipitation
with anti-FLAG agarose beads for 3 h. The beads were washed
and the genomic DNA fragments were eluted for identification of
various promoter regions by PCR (Table S3). The experiments
were repeated two times.
Statistical analysis
The unpaired two-tailed t test was used for statistical analysis.
Microsoft Excel software was used for calculation of P values. A P
value,0.05 was considered significant. Data are presented as
mean 6 SEM.
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